ACT Genomics is an internationally-recognized award-winning cancer solution provider. Combining our expertise in the fields of cancer genomics and bioinformatics with our cutting-edge technologies, we are able to assist medical practitioners and scientists with genomics-driven recommendations and data for cancer treatment strategy and discovery.
Turning Genomics Into Action
ACT Genomics is a leading genomics diagnostics and research company specializing in precision medicine for cancer patients. Our technology empower clinicians and patients to make informed decisions about cancer treatment options.
Comprehensive genomic profiling for personalised cancer treatment
The ability to perform a comprehensive genomic profiling test on an individual tumor helps open the door for personalized medicine, and a future where a person is matched with a treatment that targets the specific weaknesses in his or her cancer.
Actionable Cancer Solutions
We aim to reimagine and positively impact cancer management by using both our knowledge of cancer genomics and advanced technology capabilities. We partner with physicians to facilitate the best personalised treatment decisions for patients.
The First Asia-Based Company to Receive FDA Clearance
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors